Dr Karsten Brandt joins InQpharm on 1st May 2010 as Scientific Advisor to further strengthen the company’s research and development team. The appointment brings extensive research and development expertise and Dr Brandt will be working both with the R&D team at InQpharm’s headquarters in Malaysia and their European affiliate company in Berlin.
Dr Karsten Brandt has over 10 years’ experience in academic and industry research and will have an advisory and training role with the research and development team at InQpharm’s headquarters in Malaysia. With a PhD in Science and specialising in fat metabolism and the control of food intake, Karsten will provide support to the scientific research area, which includes pre-clinical and clinical research and the development of pipeline products across the various therapeutic areas and regulatory regions.
Thomas Hafner, Chief Executive Officer, comments: “Our ambitious and challenging plans mean that we are expanding rapidly and InQpharm needs further dynamic people to join our team. We have identified the need for extra high-level support in research and development to help us to achieve our mission of innovating effective and safe therapeutic products for a healthier life. Karsten is an important new member of our team who will help us to further strategise and execute the company’s research and development activities. We are delighted that Karsten has chosen to join InQpharm and look forward to working with him in developing the exciting plans we have for the company.”
For further information please email: enquiries@inqpharm.com